Pure Global

Qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy - India CDSCO Medical Device Registration

Qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000211_d2754a71db42c52ac7b79983121d6d14_5344cd63d36fd02154e71a64ee072263. This device is marketed under the brand name Actim Prom. The license holder is Advy Chemical Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy
UID: IMP/IVD/2019/000211_d2754a71db42c52ac7b79983121d6d14_5344cd63d36fd02154e71a64ee072263

Brand Name

Actim Prom

Device Class

Class B

Approving Authority

CDSCO

Product Information

Actimยฎ Partus test is a visually interpreted, qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (Actim Prom) in cervical secretions during pregnancy. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing